News

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...
Many of the directions included in the order will be familiar to those who watched drug pricing policy closely during the ...
In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that ...